AAG
NVO

Armstrong Advisory Group’s Novo Nordisk NVO Stock Holding History

Armstrong Advisory Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.3K Buy
715
+600
+522% +$25.8K ﹤0.01% 501
2026
Q1 		$4.23K Hold
115
– – ﹤0.01% 797
2025
Q4 		$5.85K Sell
115
-93
-45% -$4.76K ﹤0.01% 756
2025
Q3 		$11.5K Sell
208
-270
-56% -$15.8K ﹤0.01% 650
2025
Q2 		$33K Buy
478
+118
+33% +$8.03K ﹤0.01% 460
2025
Q1 		$31K Hold
360
– – ﹤0.01% 449
2024
Q4 		$31K Sell
360
-81
-18% -$8.76K ﹤0.01% 449
2024
Q3 		$52.5K Sell
441
-587
-57% -$78.3K ﹤0.01% 360
2024
Q2 		$147K Buy
+1,028
New +$136K 0.01% 217

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return

Armstrong Advisory Group's NVO Position: Q2 2026 in Review

Armstrong Advisory Group increased its Novo Nordisk (NVO) stake by 522% in Q2 2026, buying an estimated $25.8K and bringing the position to 715 shares worth $34.3K. The position accounts for ﹤0.01% of the portfolio, ranked #501.

Armstrong Advisory Group first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $147K in Q2 2024. 270 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Armstrong Advisory Group held 715 shares of Novo Nordisk worth $34.3K as of Q2 2026.
  • Armstrong Advisory Group bought 600 Novo Nordisk shares in Q2 2026, an estimated $25.8K.
  • Novo Nordisk made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #501 holding.
  • Armstrong Advisory Group first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
  • Armstrong Advisory Group's Novo Nordisk position peaked at $147K in Q2 2024.
  • 270 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.